Lampert Mark N Insider Trades

Insider Trading History

Track insider trading activity for Lampert Mark N. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $28.9M 257,754 shares
Last Trade
Aug 22, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$863k 27,117 shares
$31.83
$112.08
CTI BioPharma
CTI BioPharma CTIC
Director
Holding Value $1.53M 168,573 shares
Last Trade
Aug 09, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.7M 2,890,723 shares
$6.12
$9.10
CTI BioPharma
CTI BioPharma CTIC
Director
Holding Value $0 0 shares
Last Trade
Aug 09, 2022 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$22.7k 3,640 shares
$6.23
$9.10
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.34M 12,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 12,000 shares
$14.18
$112.08
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $11.8M 4,443,423 shares
Last Trade
Jun 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$950k 74,666 shares
$12.73
$2.65
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $34.4M 2,906,659 shares
Last Trade
Jun 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$167k 41,417 shares
$4.03
$11.85
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $8.56M 3,228,539 shares
Last Trade
Jun 02, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.18M 258,797 shares
$12.29
$2.65
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Director
Holding Value $72.1M 4,058,854 shares
Last Trade
Jun 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.46M 405,641 shares
$11.00
$17.77
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $25.8M 230,637 shares
Last Trade
May 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.6k 3,223 shares
$14.78
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $228M 2,036,860 shares
Last Trade
May 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.4k 5,883 shares
$14.00
$112.08
XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th
XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th XOMAO
Director
Holding Value $225k 8,996 shares
Last Trade
May 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$227k 8,996 shares
$25.25
$25.00
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $830k 313,357 shares
Last Trade
May 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.7k 5,730 shares
$8.50
$2.65
XOMA Royalty
XOMA Royalty XOMA
Director
Holding Value $361k 8,996 shares
Last Trade
May 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$161k 8,996 shares
$17.86
$40.17
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Director
Holding Value $5.68M 319,415 shares
Last Trade
May 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$162k 17,744 shares
$9.14
$17.77
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $164M 1,466,364 shares
Last Trade
May 05, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.38M 70,439 shares
$19.60
$112.08
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Director
Holding Value $39M 2,196,240 shares
Last Trade
Apr 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 9,402 shares
$10.75
$17.77
CTI BioPharma
CTI BioPharma CTIC
Director
Holding Value $728k 80,000 shares
Last Trade
Mar 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$359k 80,000 shares
$4.49
$9.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up